It is an analysis that the EU's policy to restrict the export of the COVID-19 vaccine produced in Korea is highly likely to affect Korea.

In particular, it is expected that the recent restriction on the export of AstraZeneca vaccine produced in Italy to Australia could directly affect the supply and demand of vaccines in Korea. This is because the AZ imported vaccine, which is currently undergoing approval review, is a product manufactured in Italy.

According to foreign media, on the 4th, AstraZeneca requested export to Australia for 250,000 doses of COVID-19 vaccine produced at the Italian factory, but was rejected by EU authorities.

The EU has a policy to allow export by